- Home
- Publications
- Publication Search
- Publication Details
Title
Diabetes Mellitus Secondary to Cushing’s Disease
Authors
Keywords
-
Journal
Frontiers in Endocrinology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-06-04
DOI
10.3389/fendo.2018.00284
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial
- (2018) André Lacroix et al. Lancet Diabetes & Endocrinology
- Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management
- (2017) Carla Scaroni et al. ENDOCRINE REVIEWS
- Urinary tract and genital infections in patients with type 2 diabetes treated with sodium-glucose co-transporter 2 inhibitors: A meta-analysis of randomized controlled trials
- (2016) Dandan Li et al. DIABETES OBESITY & METABOLISM
- Cabergoline for Cushing’s disease: a large retrospective multicenter study
- (2016) A Ferriere et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Effects of cabergoline on blood glucose levels in type 2 diabetic patients
- (2016) Adele Bahar et al. MEDICINE
- The Role of Isotretinoin Therapy for Cushing’s Disease: Results of a Prospective Study
- (2016) Lucio Vilar et al. International Journal of Endocrinology
- A review of dopamine agonist therapy in type 2 diabetes and effects on cardio-metabolic parameters
- (2016) E.M. Lamos et al. Primary Care Diabetes
- Complications of Cushing's syndrome: state of the art
- (2016) Rosario Pivonello et al. Lancet Diabetes & Endocrinology
- Glucocorticoids suppress GLP-1 secretion: possible contribution to their diabetogenic effects
- (2015) Camilla Kappe et al. CLINICAL SCIENCE
- Reduction of insulinotropic properties of GLP-1 and GIP after glucocorticoid-induced insulin resistance
- (2015) Marie Eriksen et al. DIABETOLOGIA
- The Treatment of Cushing's Disease
- (2015) Rosario Pivonello et al. ENDOCRINE REVIEWS
- Efficacy of a basal bolus insulin protocol to treat prednisolone-induced hyperglycaemia in hospitalised patients
- (2015) M. G. Burt et al. INTERNAL MEDICINE JOURNAL
- SGLT2 Inhibitors May Predispose to Ketoacidosis
- (2015) Simeon I. Taylor et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline
- (2015) Lynnette K. Nieman et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effectiveness of Metyrapone in Treating Cushing's Syndrome: A Retrospective Multicenter Study in 195 Patients
- (2015) Eleni Daniel et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Endocrine role of bone: recent and emerging perspectives beyond osteocalcin
- (2015) K. J. Oldknow et al. JOURNAL OF ENDOCRINOLOGY
- Cushing's syndrome
- (2015) André Lacroix et al. LANCET
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Osilodrostat, a potent oral 11β-hydroxylase inhibitor: 22-week, prospective, Phase II study in Cushing’s disease
- (2015) Maria Fleseriu et al. Pituitary
- Italian Society for the Study of Diabetes (SID)/Italian Endocrinological Society (SIE) guidelines on the treatment of hyperglycemia in Cushing’s syndrome and acromegaly
- (2015) M. G. Baroni et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Ketoconazole in Cushing's Disease: Is It Worth a Try?
- (2014) Frederic Castinetti et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Up-to 5-year efficacy of pasireotide in a patient with Cushing’s disease and pre-existing diabetes: literature review and clinical practice considerations
- (2014) Laura Trementino et al. Pituitary
- Therapeutic strategies for Cushing’s syndrome: an update
- (2014) Filippo Ceccato et al. Expert Opinion on Orphan Drugs
- Diagnosis and complications of Cushing's disease: gender-related differences
- (2013) Marialuisa Zilio et al. CLINICAL ENDOCRINOLOGY
- The Future of Thiazolidinedione Therapy in the Management of Type 2 Diabetes Mellitus
- (2013) Hanford Yau et al. Current Diabetes Reports
- Improvement in Insulin Sensitivity During Mifepristone Treatment of Cushing Syndrome:Early and Late Effects
- (2013) Amisha Wallia et al. DIABETES CARE
- Inhibition of the sodium glucose co-transporter-2: its beneficial action and potential combination therapy for type 2 diabetes mellitus
- (2013) L. H. Chen et al. DIABETES OBESITY & METABOLISM
- Management of hyperglycemia associated with pasireotide (SOM230): Healthy volunteer study
- (2013) Astrid Breitschaft et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Is diabetes in Cushing's syndrome only a consequence of hypercortisolism?
- (2013) Carla Giordano et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Hyperglycemia Associated With Pasireotide: Results From a Mechanistic Study in Healthy Volunteers
- (2013) Robert R. Henry et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- LCI699, a Potent 11β-hydroxylase Inhibitor, Normalizes Urinary Cortisol in Patients With Cushing's Disease: Results From a Multicenter, Proof-of-Concept Study
- (2013) Xavier Bertagna et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Metabolic functions of glucocorticoid receptor in skeletal muscle
- (2013) Taiyi Kuo et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Glucocorticoids and the regulation of growth hormone secretion
- (2013) Gherardo Mazziotti et al. Nature Reviews Endocrinology
- Treatment of skeletal impairment in patients with endogenous hypercortisolism: when and how?
- (2013) A. Scillitani et al. OSTEOPOROSIS INTERNATIONAL
- Combination therapy for Cushing’s disease: effectiveness of two schedules of treatment. Should we start with cabergoline or ketoconazole?
- (2013) M. Barbot et al. Pituitary
- Managing hyperglycemia in patients with Cushing’s disease treated with pasireotide: medical expert recommendations
- (2013) Annamaria Colao et al. Pituitary
- Effects of exenatide and liraglutide on heart rate, blood pressure and body weight: systematic review and meta-analysis
- (2013) Louise E Robinson et al. BMJ Open
- A reappraisal of the medical therapy with steroidogenesis inhibitors in Cushing's syndrome
- (2012) Elena Valassi et al. CLINICAL ENDOCRINOLOGY
- Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2012) S. E. Inzucchi et al. DIABETOLOGIA
- Efficiency and tolerance of mitotane in Cushing's disease in 76 patients from a single center
- (2012) Camille Baudry et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Prevalence of diabetes mellitus in 6050 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysis
- (2012) Roger Abs et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Potential Role for Retinoic Acid in Patients with Cushing's Disease
- (2012) Francesca Pecori Giraldi et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Mifepristone, a Glucocorticoid Receptor Antagonist, Produces Clinical and Metabolic Benefits in Patients with Cushing's Syndrome
- (2012) Maria Fleseriu et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Osteoblasts mediate the adverse effects of glucocorticoids on fuel metabolism
- (2012) Tara C. Brennan-Speranza et al. JOURNAL OF CLINICAL INVESTIGATION
- A 12-Month Phase 3 Study of Pasireotide in Cushing's Disease
- (2012) Annamaria Colao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association of glucocorticoid receptor polymorphism A3669G with decreased risk of developing diabetes in patients with Cushing's syndrome
- (2011) Laura Trementino et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Mitotane, Metyrapone, and Ketoconazole Combination Therapy as an Alternative to Rescue Adrenalectomy for Severe ACTH-Dependent Cushing's Syndrome
- (2011) Peter Kamenický et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Pasireotide (SOM230), a Novel Multireceptor-Targeted Somatostatin Analogue, Is Well Tolerated When Administered as a Continuous 7-Day Subcutaneous Infusion in Healthy Male Volunteers
- (2011) Stephan Petersenn et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Diabetes in Cushing syndrome: basic and clinical aspects
- (2011) Gherardo Mazziotti et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Bromocriptine: old drug, new formulation and new indication
- (2010) R. I. G. Holt et al. DIABETES OBESITY & METABOLISM
- Efficacy of Cabergoline in Uncured (Persistent or Recurrent) Cushing Disease After Pituitary Surgical Treatment with or without Radiotherapy
- (2010) Anurag Lila et al. Endocrine Practice
- Cabergoline monotherapy in the long-term treatment of Cushing's disease
- (2010) Ariane Godbout et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Ketoconazole enantiomer for the treatment of diabetes mellitus
- (2010) Richard Arakaki et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Medical Treatment of Cushing’s Disease: Somatostatin Analogues and Pasireotide
- (2010) Alberto M. Pedroncelli NEUROENDOCRINOLOGY
- Management of Diabetes Mellitus in Cushing’s Syndrome
- (2010) Alia Munir et al. NEUROENDOCRINOLOGY
- Pathophysiology of Diabetes Mellitus in Cushing’s Syndrome
- (2010) Rosario Pivonello et al. NEUROENDOCRINOLOGY
- Pasireotide Alone or with Cabergoline and Ketoconazole in Cushing's Disease
- (2010) Richard A. Feelders et al. NEW ENGLAND JOURNAL OF MEDICINE
- Alogliptin added to insulin therapy in patients with type 2 diabetes reduces HbA1cwithout causing weight gain or increased hypoglycaemia
- (2009) J. Rosenstock et al. DIABETES OBESITY & METABOLISM
- Effects of Growth Hormone on Glucose, Lipid, and Protein Metabolism in Human Subjects
- (2009) Niels Møller et al. ENDOCRINE REVIEWS
- Novel insights into glucocorticoid-mediated diabetogenic effects: towards expansion of therapeutic options?
- (2009) D. H. van Raalte et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Differential Ligand-Mediated Pituitary Somatostatin Receptor Subtype Signaling: Implications for Corticotroph Tumor Therapy
- (2009) Anat Ben-Shlomo et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- All-trans-Retinoic Acid Represses Obesity and Insulin Resistance by Activating both Peroxisome Proliferation-Activated Receptor / and Retinoic Acid Receptor
- (2009) D. C. Berry et al. MOLECULAR AND CELLULAR BIOLOGY
- Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis
- (2008) Y. K. Loke et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Ketoconazole revisited: a preoperative or postoperative treatment in Cushing's disease
- (2008) F Castinetti et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Treatment of Adrenocorticotropin-Dependent Cushing’s Syndrome: A Consensus Statement
- (2008) B. M. K. Biller et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Treatment of Pituitary-Dependent Cushing’s Disease with the Multireceptor Ligand Somatostatin Analog Pasireotide (SOM230): A Multicenter, Phase II Trial
- (2008) M. Boscaro et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Medical Treatment of Cushing’s Disease: Effectiveness of Chronic Treatment with the Dopamine Agonist Cabergoline in Patients Unsuccessfully Treated by Surgery
- (2008) Rosario Pivonello et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
- (2008) Rury R. Holman et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now